Cell Therapy Selection Guide: Connected From Activation To Expansion

CTS Detachable Dynabeads magnetic beads address passive bead dissociation bottlenecks directly with a proprietary active release mechanism that puts control back in the hands of process developers. By combining paramagnetic bead technology with single-domain VHH antibodies and a proprietary active release mechanism, these next-generation beads give manufacturers on-demand control over bead removal at any workflow stage.
The result is faster processing, higher T cell purity and viability, and a scalable platform compatible with closed, automated manufacturing systems. Download this brochure to learn how CTS Detachable Dynabeads can strengthen your cell therapy manufacturing workflow from activation through expansion.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.